Results 1 to 10 of about 1,334,767 (332)
Aspergillosis in Chronic Granulomatous Disease [PDF]
Journal of Fungi, 2016 Patients with chronic granulomatous disease (CGD) have the highest life-time incidence of invasive aspergillosis and despite the availability of antifungal prophylaxis, infections by Aspergillus species remain the single most common infectious cause of ...
Jill King +2 more
doaj +4 more sources
Chronic granulomatous disease [PDF]
British Medical Bulletin, 2016 Chronic granulomatous disease is a clinical condition that stems from inactivating mutations in NOX2 and its auxiliary proteins. Together, these proteins form the phagocyte NADPH oxidase enzyme that generates superoxide. Superoxide (O2ċ-) and its reduced product hydrogen peroxide (H2O2) give rise to several additional reactive oxygen species (ROS ...
Amit, Rawat +2 more
semanticscholar +10 more sources
Chronic granulomatous disease: the European experience. [PDF]
PLoS ONE, 2009 CGD is an immunodeficiency caused by deletions or mutations in genes that encode subunits of the leukocyte NADPH oxidase complex. Normally, assembly of the NADPH oxidase complex in phagosomes of certain phagocytic cells leads to a "respiratory burst ...
J Merlijn van den Berg +18 more
doaj +17 more sources
Chronic granulomatous disease [PDF]
Indian Dermatology Online Journal, 2015 Chronic Granulomatous Disease (CGD) is an inherited immunodeficiency disorder characterized by defective functioning of NADPH oxidase enzyme in the phagocytes.
Kikkeri Narayanasetty Naveen +1 more
doaj +6 more sources
Cellular Therapies in Chronic Granulomatous Disease
Frontiers in Pediatrics, 2020 Allogeneic hematopoietic stem cell transplantation (HSCT) has become the main curative treatment in patients with chronic granulomatous disease (CGD). CGD is caused by inherited defects of the phagolysomal NADPH-oxidase, leading to a lifelong propensity ...
Tayfun Güngör, Robert Chiesa
doaj +2 more sources
Inherited p40phox deficiency differs from classic chronic granulomatous disease [PDF]
Journal of Clinical Investigation, 2018 Biallelic loss-of-function (LOF) mutations of the NCF4 gene, encoding the p40phox subunit of the phagocyte NADPH oxidase, have been described in only 1 patient. We report on 24 p40phox-deficient patients from 12 additional families in 8 countries.
Dinauer, Mary C, et al,
core +3 more sources
Recent advances in chronic granulomatous disease
Genes and Diseases, 2020 Chronic granulomatous disease (CGD) is an inherited defect of phagocyte function due to defective NADPH oxidase. Patients with CGD are not able to effectively clear the infections because of the defect in the phagocyte production of oxygen free radicals ...
Gummadi Anjani +6 more
doaj +2 more sources
Frontiers in Immunology, 2021 Chronic granulomatous Disease (CGD) is a rare innate immunodeficiency disorder caused by mutations in one of the six genes (CYBA, CYBB, NCF1, NCF2, NCF4, and CYBC1/EROS) encoding the superoxide-producing nicotinamide adenine dinucleotide phosphate (NADPH)
Faris Ghalib Bakri +20 more
doaj +1 more source
A case of chronic granulomatous disease and acne: is isotretinoin a safe treatment?
Dermatology Reports, 2022 We report the case of a patient with chronic granulomatous disease and acne treated with isotretinoin, who developed a diffuse staphylococcal skin infection during the therapy. Chronic granulomatous disease is a rare genetic disorder characterized by an
Marco Brusasco +2 more
doaj +1 more source
Chronic Granulomatous Disease (CGD): Commonly Associated Pathogens, Diagnosis and Treatment
Microorganisms, 2023 Chronic granulomatous disease (CGD) is a primary immunodeficiency caused by a defect in the phagocytic function of the innate immune system owing to mutations in genes encoding the five subunits of the nicotinamide adenine dinucleotide phosphatase (NADPH)
A. Justiz-Vaillant +8 more
semanticscholar +1 more source